Professional Documents
Culture Documents
Cart
Search in:
Journal
Review article
Download citation
http://dx.doi.org/10.3109/15376516.2016.1139024
Crossmark
Select Language
Translator disclaimer
Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
Get access
Abstract
Shibboleth OpenAthens
Username Password
Forgot password?
Remember Me Log in
Or purchase it *
Toxicology Mechanisms and Methods
Volume 26 2016 - Issue 3
Add to cart
Add to cart
Earth Sciences
Economics, Finance, Business & Industry
Education
Engineering & Technology
Environment & Agriculture
Environment and Sustainability
Food Science & Technology
Geography
Information for
Authors
Editors
Librarians
Societies
Open access
Overview
Open journals
Open Select
Cogent OA
Informa Group plc Privacy policy & cookies Terms & conditions Accessibility
Accept
This website uses cookies to ensure you get the best experience on our website
Blog
Support H&E
About & Contact
Feature Article Archive
Search this
Update, October 2011: Read more about how EDCs can have effects at low doses in our 2-
part series. Part 1: Are EDCs too swamped by natural hormones to have an effect? and Part
2: About why being less attracted to receptors than natural hormones does not mean EDCs
have less effect.
A new study [EHP 117:10531058 (2009); Bouskine et al.] has shed some light on how
bisphenol-A (BPA) can substantially interfere with hormone signalling within the body,
even though it is a relatively weak xenoestrogen.
As regular readers of H&E will know, BPA is an increasingly controversial chemical additive
commonly used in plastics such as food packaging and medical devices.
Concerns centre on its ability to mimic the hormone oestrogen, but sceptics of the potential
for BPA to harm health argue that it is too weak a hormone to have an effect on cell function.
Here, we sketch out a mechanism by which BPA could have a much stronger effect than the
sceptics argue, via an indirect pathway rather than a direct effect on the part of the cell
nucleus which responds to oestrogen.
Note: We have tried to make this article as accessible as possible; if you are familiar with the
cellular processes described, please be patient with our slightly long-winded explanation. Full
references are at the bottom of this post.
KEY
ED = Endocrine Disruptor
ER = Oestrogen Receptor
E2 = Oestrogen
Summary: The xenoestrogen BPA can stimulate cell proliferation and endocrine disruption
at extremely low levels by acting on a G Protein Coupled Receptor. BPA does not therefore
need to be present at the high levels needed for it to affect the nuclear Oestrogen Receptor
(ER) in order to have a substantial effect.
by Dr John Newby, Medical Information Scientist, Cancer Prevention and Education Society
One of the main arguments against the idea that endocrine disruptors (EDs) such as BPA can
have adverse health effects at low levels, is the oestrogenicity of such EDs at
environmentally relevant levels is too weak to have an effect.
The argument is based on how EDs like BPA interact with the Oestrogen Receptor (ER-alpha
or beta), found in the cell nucleus.
When ER is bound to oestrogen (E2), ER-E2 acts as a transcription factor, which regulates
gene expression: the E2-ER complex binds to the DNA and regulates gene activity.
This may increase cell proliferation, especially during developmental periods, fetal, puberty,
menses etc. This is a genomic effect.
Editors note: The fact that BPA may increase proliferation is important to later understand
why diethylstilbestrol (a highly problematic drug given to women between 1940 and 1980 to
prevent miscarriage, and structurally similar to BPA) has a suppressive effect. We will return
to this topic in a later post.
To get ER-mediated responses (genomic) with BPA or other EDs, very high concentrations
are usually needed because they have a weaker affinity for the receptor. Sceptics often jump
on this fact to say that BPA is not around at levels high enough to act directly on the ER and
cause disruption.
The significance of the Bouskine study is that it shows a way in which BPA can act indirectly
of the classic ER and exert effects at low doses, through a non-genomic rather than genomic
pathway.
This is because of the way signalling works within cells: cells have receptors on their
membranes, a bit like an antenna, which receive low level signals from, for example,
hormones, drugs and xenochemicals.
The membrane receptors then transmit this signal elsewhere within the cell. One such
membrane protein is a G protein. The signal is passed on from the G protein via what is
known as a 2nd messenger.
The role of the 2nd messenger is to amplify the signal to make it much more effective. Thus
an initial low-level signal will turn into a much stronger signal at the target.
The G protein in this study is called a G-protein coupled oestrogen receptor and can be
activated by both oestrogen and BPA at picomolar (parts per trillion) or nanomolar (parts per
billion) levels, which in turn activates transcription factors via 2nd messengers (which is non-
genomic).
In this case the BPA mediates (via G protein and 2nd messengers) a chemical activation of
two transcription factors, one called CREB and one called Rb. Rb is a cell cycle regulator,
which helps govern cell division. Interference with this process, especially during critical
windows of development, could have a range of permanent health effects [see H&E issue 13,
PDF].
Thus we have a process in which low levels of BPA can cause endocrine disruption and
possible adverse effects despite its low oestrogenicity, because only pico (10^12 M) or
nanomolar (10^9 M) levels, are needed to elicit a response via the G protein coupled receptor
mechanism.
These are the sorts of concentrations found in peoples blood, and far lower than the BPA
levels needed for a genomic ER response, which are around micromolar (10-6 M) levelsand
1,000 to 1,000,000 times higher.
Other EDs have been shown to act indirectly too. In one of my studies [Newby and Howard,
2005], I describe a mechanism whereby weakly oestrogenic PCBs can interfere with the
action of an enzyme (SULTE 1E1) which breaks down and aids excretion of oestrogen and
therefore regulates the amount of oestrogen that is bioavailable in the body [Kester et al.,
2000; Kester et al., 2002].
In this case, if PCBs bind to the enzyme then more oestrogen is bioavailable to oestrogen
sensitive tissues such as the testes/ mammary glands, and could cross the placenta resulting in
increased oestrogen in the fetal bloodstream. This provides a mechanism where PCBs,
although very weak oestrogens, could act to disrupt the endocrine system indirectly.
References
Share this:
Facebook1
Google
Twitter
LinkedIn
More
Related
A Health & Environment retrospective: concerns that talking about causes of cancer can
cause cancer; the difficulties of defining "endocrine disruptor"; shedding light on the
obesogen hypothesis; and more.In "Feature Articles"
2 Comments
RSS feed for comments on this post. TrackBack URI
1. [] Pete Myers, founder and CEO of Environmental Health Sciences and author of
Our Stolen Future, helpfully pointed out the following items which follow the same
line of thought we expressed in proposing a mechanism for how BPA can act as a
powerful endocrine disruptor. []
Pingback by Follow-up: More on how weak oestrogen BPA can act as a powerful endocrine
disruptor Health & Environment July 17, 2009 #
Reply
2. [] Even though BPA is a weak oestrogen, there is a mechanism by which low levels
of BPA could have a po. It is often argued that BPA is too weak a hormone to have
an effect on cell function. Here, we sketch out a mechanism by which BPA could
potentially have a strong effect via an indirect pathway rather than a direct effect on
the part of the cell nucleus which responds to oestrogen. (July 2009) []
Pingback by A Health & Environment retrospective: concerns that talking about causes of cancer can
cause cancer; the difficulties of defining endocrine disruptor; shedding light on the obesogen
hypothesis; and more. | Health & Environment August 14, 2013 #
Reply
Leave a Reply
Health & Environment is the newsletter of the Cancer Prevention and Education
Society: exploring emerging issues in environmental health science and policy-
making.
Blog follow
Enter your email address to follow this blog and receive notifications of new posts by
email.
Monthly Subscribe
Each month we produce two science digests (1 human, 1 miscellaneous), a news
digest and a brief editorial. Click here to subscribe to our monthly email update, to
make sure you don't miss anything.
Recent Posts
o Association or causation? A need for transparency of process
o October 2016 News Bulletin: FDA rules on triclosan safety; childhood cancer
rates up 40%
o October 2016 Science Bulletin: Systematic review of air pollution and autism
diagnosis; phthalates increase hydrocele risk
o Fire safety without flame retardants
o September 2016 News Bulletin: Sofa safety fears; concerns raised over lax
safety testing for cosmetics
Latest News and Science
o Endocrine Aspects of Environmental "Obesogen" Pollutants
More than nine out of every 10 people on the planet live in areas where air
pollution breaches official safety limits and millions of people are dying as a
result, according to new research by the World Health Organisation (WHO).
The Commission proposals are not in line with the globally accepted approach
for identification of substances of high concern, nor with the WHO definition
of an endocrine disruptor. I am particularly worried about the fact that the
criteria only apply to substances that are known to cause an adverse effect
relevant for human health and that evidence has to b []
The use of chemical flame retardants in furniture to improve fire safety can
also have severe implications for public health, a number of associations have
warned. An alliance of stakeholders representing equipment makers,
environmental NGOs, cancer organisations, firefighters, and labour unions
have expressed concern about the safety of using flame retardan []
Blog at WordPress.com.
Entries and comments feeds.
About Bisphenol A
Human Health & Safety
Environmental Safety
Scientific Publications
Press Room
Human Health & Safety >> Health Effects Research Health Effec
Research
Endocrine Activity Studies on Bisphenol A General Toxi
Background on Endocrine Disruption Carcinogenic
Endocrine Disruption and Bisphenol A
Estrogenic Activity of Bisphenol A Reproductive
Low-Dose Endocrine Effects Developme
Toxicity
Endocrine Ac
Background on Endocrine Disruption
Low-Dose En
Our Stolen Future, a book published in 1996, popularized the Effects
theory that natural and man-made substances that exhibit
hormone-like properties in the laboratory can affect wildlife Metabolism
populations, thus speculating that humans may be at risk of
"hormone disruption." While this theory has been widely Health Effect
discussed in the open scientific literature, it caught the public's Research Ref
attention resulting in a U.S. Congressional mandate to test man-
made chemicals for any hormonal properties.
Since that time there have been hundreds of published studies Join the Bisp
testing the hypothesis, including assays that show a positive mailing list.
response. These assays are often misused to label certain email addre
substances "endocrine disrupters," although a more accurate
term, "hormonally active agents," was recently coined by the
U.S. National Academy of Sciences.
More Info